TransCelerate Bio Pharma Inc (TransCelerate)

See the following -

TransCelerate BioPharma Inc. Releases First Update On Risk-Based Monitoring Of Clinical Trials Initiative, Yields Key Lessons And Training Materials

Press Release | TransCelerate BioPharma Inc. | January 30, 2014

In its continued effort to modernize and streamline the way clinical trials are conducted and monitored, TransCelerate BioPharma Inc.  ("TransCelerate") is providing the first update to its position paper outlining a methodology for risk-based site monitoring ("Risk-Based Monitoring" or "RBM") released in June 2013. Read More »